Skip to main content
. Author manuscript; available in PMC: 2017 Sep 15.
Published in final edited form as: Clin Cancer Res. 2016 Apr 27;22(18):4612–4622. doi: 10.1158/1078-0432.CCR-15-2703

Table 1.

Multivariate Cox regression analysis showing the relationship between different covariates, including an interaction between WRN methylation and treatment arm, and progression free survival

Covariate HR 95% CI p-value*
treatment arm 0.47 0.32–0.70 0.0002
WRN methylation status 0.36 0.14–0.98 0.05
previous adjuvant therapy 1.65 1.09–2.50 0.02
serum LDH 1.52 1.07–2.15 0.02
WHO performance status 1.18 0.89–1.56 0.26
gender 0.74 0.52–1.04 0.09
age 0.99 0.98–1.01 0.51
location of metastases 1.10 0.85–1.43 0.45
interaction of treatment arm and WRN methylation status 2.11 1.13–3.92 0.02

Analysis based on 182 samples, of which 179 events (1 observation deleted due to missingness)

CI, confidence interval; HR, hazard ratio; WRN, Werner gene; LDH, Lactate dehydrogenase; WHO, World Health Organisation

*

Wald test